Abstract
The synthesis of new fluorinated pyrrolidones starting from unprotected amino esters and amino nitriles through a Michael addition-lactamization sequence is described. The resulting CF3 -containing building blocks, bearing a quaternary stereogenic center adjacent to the fluorinated group, have been converted into amino pyrrolidines that display potent β-secretase 1 (BACE1) inhibitory activity. This work constitutes an example of selective fluorination as a valid strategy for the modulation of physicochemical and biological properties of lead compounds in drug discovery.
Keywords:
cyclization; drug discovery; enzymes; fluorine; inhibitors.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Amidines / chemical synthesis*
-
Amidines / pharmacology*
-
Amyloid Precursor Protein Secretases / antagonists & inhibitors*
-
Amyloid Precursor Protein Secretases / chemistry*
-
Aspartic Acid Endopeptidases / antagonists & inhibitors*
-
Aspartic Acid Endopeptidases / chemistry*
-
Cyclization
-
Drug Discovery
-
Hydrocarbons, Fluorinated / chemistry*
-
Hydrocarbons, Fluorinated / pharmacology*
-
Molecular Structure
-
Pyrrolidinones / chemistry*
-
Pyrrolidinones / pharmacology*
-
Stereoisomerism
Substances
-
Amidines
-
Hydrocarbons, Fluorinated
-
Pyrrolidinones
-
Amyloid Precursor Protein Secretases
-
Aspartic Acid Endopeptidases
-
BACE1 protein, human
-
2-pyrrolidone